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Pulmonary gas exchange during hemodialysis. Pulmonary gas ex-
change was continuously measured in 13 mechanically ventilated pa-
tients during 24 hemodialyses for acute renal failure. Minute—ventilation
was maintained constant by controlled ventilation and gas exchange
was continuously measured by a mass—spectrometer system, Three
groups were compared: 1) a cuprophan membrane with an acetate
dialysate; 2) a polyacrilonitrile membrane (PAN) with an acetate
dialysate; and 3) PAN with a bicarbonate dialysate. Arterial P02 and the
02 alveolar—arterial gradient were the same regardless of the membrane
used. H1 mildly decreased with all dialysates used. Arterial PCO2
decreased only with the acetate dialysate. 0 consumption increased,
up to 20 5% of the initial values during hemodialysis, and remained
increased during the two hours following the hemodialysis. Respiratory
exchange ratio was lower after than before the hemodialysis. In
conclusion: I) the maintenance of a constant minute ventilation pre-
vented hemodialysis induced hypoxemia. 2) V02 increased during
hemodialysis.
Hemodialysis (HD) with an acetate dialysate can be respon-
sible for hypoxemia in chronic renal failure. Craddock and
co-workers [1] pointed out the role of the dialysis membrane
with poor biocompatibility (cuprophan). They suggested venti-
lation to perfusion (VA/Q) inequalities as the main cause of
arterial hypoxemia. Subsequent experimental [21 and clinical [3]
studies using inert gas analysis showed that there was no
worsening in VA/Q relationships during HD. Alveolar hypoven-
tilation due to carbon dioxide (C02) loss into the acetate
dialysate appears, therefore, to be the main factor of arterial
oxygenation impairment. When the acetate dialysate is replaced
by a bicarbonate one, hypoxemia has also been described [4—6]
and attributed to an alveolar hypoventilation secondary to a
metabolic alkalosis. However, hypoxemia has also been re-
ported in patients in which alveolar hypoventilation was pre-
vented by mechanical ventilation [7, 8].
Moreover, changes in oxygen consumption (V02) during I-ID
remain a matter of controversy. V02 was found lobe decreased
[9, 10], unchanged [3,7, 11—13] or increased 114—16] during HD
with an acetate as well as a bicarbonate dialysate. The discrep-
ancies between these findings could have been the result of
differences in study design, particularly the choice of patients,
the measurement methods, and the time course of data collec-
tion.
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The objective of this study was to determine the effect of RD
on arterial oxygenation and V02 in mechanically ventilated
patients with acute renal failure. Two types of dialysis mem-
brane Icuprophan (cupro) and polyacrilonitrilc (PAN)I and two
types of dialysate [acetate (Ac), bicarbonate (Bic)] were used.
Pulmonary gas exchange was measured continuously by a mass
spectrometer system,
Methods
Patients
Thirteen patients (mean age: 60 14 years, range: 28 to 76)
treated for acute renal failure and requiring mechanical venti-
lation were studied. They were hospitalized in our intensive
care unit for a neurological disease and/or a severe sepsis (Table
1). At the time of the study, they were mechanically ventilated
from six to 11 days and had stable hemodynamic state and core
temperature. Pa02 was above 8 kPa with an F102 tinder 0,4 in
all patients. Patients were given intravenous sedation as neces-
sary to tolerate mechanical ventilation. Siemens' Servo venti-
lators were used in the control mode for all patients, thus
keeping the minute ventilation constant (13 0.8 liter min')
and the PaCO2 within the normal range. All patients had central
venous and peripheral arterial catheters. During the study,
glucose infusion was constant and no lipid solutions were
infused.
This protocol was approved by the ethical committee of our
institution, and informed consent was obtained from the nearest
relatives.
Protocol
Group 1 (Ac Cupro). For patient 1 to patient 8, RD was
performed with an acetate dialysate (35 mmoles liter) and a
cuprophan membrane (parallel flow, 1.4 m2, Bellco). Two hours
before the beginning of HD, the mass spectrometer system was
set up for an eight hour period. Hemodynamic parameters were
monitored throughout the study and the core temperature was
measured three times. Blood samples were taken according to
Table 2. Each session of HD, made without loss of weight,
lasted four hours. A single pass system (Monitral Hospal or
BL714 Beilco) was used. Access to blood was provided by a
single venous catheter. Sessions were performed with a double
blood pump and with the usual heparinization. The dialysate
flow was 500 ml ' min.
Group 2 (Ac PAN). For the same eight patients, III) was
performed with the acetate dialysate and a polyacrilonitrile
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Table 1. Patient's clinical characteristics
Patient Sex Age Diagnosis
1
2
3
4
5a678
9
ioa
11
12
13
M
M
M
M
F
M
M
M
M
F
M
F
F
76
76
47
66
73
72
56
57
60
64
43
65
28
Head and chest trauma
Hemopathy—sepsis
Head trauma—sepsis
Hemopathy—sepsis
Thoracic surgery—sepsis
Gas gangrene
Quadriplegia—septicemia
Polyneuropathy—septicemia
Choledochal stenosis—septicemia
Colic surgery—septicemia
Septicemia—pneumopathy
Colic surgery—septicemia
Pregnancy—sepsis
a Survived.
membrane (parallel flow, 1 m2, Hospal). All the manipulations
were the same as in group 1.
Group 3 (Bic PAN). For patient 6 to patient 13, HD was
performed with a bicarbonate dialysate (30 mmoles liter)
and the polyacrilonitrile membrane. This protocol was the same
as for group 1 but no blood cell counts were done.
Measurements and calculations
Blood analysis. The samples for blood gas analysis were
collected anaerobically in heparinized plastic syringes and
immediately iced. Blood pH, P02, and PCO2 were measured
with a Corning 175 (Corning Inc., Midfield, Massachusetts,
USA), and hemoglobin concentration and oxygen saturation
with a hemoxymeter OSM2 Radiometer. Leukocyte counts and
platelet counts were made with a Coulter Counter S plus.
Pulmonary gas exchange studies
'O2 and pulmonary CO2 elimination (VCO2) were continu-
ously recorded by a mass spectrometer system (Perkin Elmer
MGA 1100, Perkin Elmer Co., Norwalk, Connecticut, USA).
Details of this procedure and thorough validation have been
given in a previous report [17]. The system can be briefly
described as follows. Gas samples were drawn from the Y piece
of the patient's breathing circuit to a mass spectrometer and
analyzed for inspired 02 concentration (F102) and CO2
wave—form recognition. The latter analysis allowed rejection of
artifacted cycles, such as coughing. Then, expired gas was
sampled from the outlet of a mixing chamber for the measure-
ments of the mixed expired 02 and CO2 concentrations. The
duration of the whole analysis sequence was about three
minutes. Expired flow was measured by a pneumotachometer
(Gould Statham Instruments, Hato Rey, Puerto Rico). All the
signals were collected by a microcomputer (Kontron) which
was programmed to reject artifacted respiratory sequences and
to compute V02, VCO2, expired minute volume, and end—tidal
CO2 partial pressure (PETCO2).
Calculations
The following formulae were used:
RE —
'TCO2/VO2 RE = respiratory exchange ratio
(A — a) 02 = PAO2 — Pa02
(A — a) 02 = alveolar—arterial gradient in 02
PAO2 = [PBAR — 6.3] FIO2 - PETCO2 [FIO2 + 1 RE'
Blood CO2 contents were calculated using PCO2 before and
after the dialyzer according to Kelman' s procedure [18].
The amount of CO2 extracted by the dialyzer (VCO2 dial) was
calculated as the product of the blood flow through the dialyzer
and the difference between blood CO2 contents before and after
the dialyzer.
TCO2 + '1C02 dialRQ = . RQ = Respiratory quotient
VO2
Volumes were expressed in BTPS conditions and metabolic
parameters (V02, VCO2) in STPD conditions.
The results were presented as the means SEM and further
statistical analysis used one—way analysis of variance and
two—way analysis of variance when necessary. Duncan's mu!-
tiple range test was used for multiple comparisons of means
whenever analysis of variance showed significance.
Results
The patients remained hemodynamically stable throughout
the study period. No patient was hypotensive. Temperature did
not change more than one degree Celsius in any patient. Minute
ventilation was constant for each patient.
Group 1. Platelet count did not change. The leukocyte count
significantly decreased at the beginning of HD (Fig. 1). Pa02,
(A — a)O2 and [H] did not change, and PaCO2 decreased (Fig.
2). As shown in Figure 3, V02 increased during HD whereas
VCO2 and RE decreased. VO2 remained increased after HD. By
comparison with the pre-dialysis values, VCO2 was unchanged
after HD. So, RE decreased after HD. The mean decrease of
VCO2 during HD was 24 7 ml. min'. The mean VCO2 dial
was 63 6 ml. min* Therefore, total CO2 elimination in-
creased by 39 ml• min; RQ was 1.06 during HD.
Group 2. Platelet and leukocyte counts did not change (Fig.
1), nor did PaO2, (A — a)O2 or [HI (Fig. 2). Changes in V02,
VCO2 and RE were parallel to those of group 1 (Fig. 3). The
mean decrease of VCO2 was 31 7 ml. min'. The mean
VCO2 dial was 59 6 ml min. Therefore, total CO2 elimi-
nation increased by 28 ml min'; RQ was 1.06 during HD.
Group 3. PaO2, PaCO2, (A — a)O2 and [H] did not change
(Fig. 2). V02 increased during and after HD. VCO2 remained
stable, RE decreased after HD (Fig. 3). There was a small
increase of CO2 in the blood across the dialyzer (5.9 1.9
ml . min1).
Discussion
During HD for acute renal failure, the maintenance of a
constant ventilation prevented hypoxemia no matter which
membrane or dialysate was used. The oxygen alveolar—arterial
gradient did not increase. These results confirm that the mech-
anism of hypoxemia during HD in a patient spontaneously
breathing must be an alveolar hypoventilation.
As experimentally demonstrated by Phillipson, Duffin and
Cooper [19], extra pulmonary excretion of CO2 by an extra
corporeal circuit leads to hypoventilation. This adaptative
mechanism, the objective of which is to maintain the PaCO2
level unchanged, is prevented by mechanical ventilation. In our
patients, the loss of CO2 into the acetate dialysate was associ-
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Blood gas analysis:
Arterial
Pre-dialyzer
Post-dialyzer
Leukocyte count and
platelet count
Table 2. Timetable of blood samples
Time, mm —120 —60 To +10 +30 +60
t_____________________ Hemodialysis
Mass spectrometer system analysis
+120 +240
I
+300 +360
I
ated with hypocapnia, whereas PaCO2 was unchanged during
HD with a bicarbonate dialysate.
The lack of hypoxemia during HD was found with both the
cuprophan and the polyacrilonitrile membrane. Therefore,
leukopenia, which has been observed at the beginning of HD
with a cuprophan membrane, was not associated with pulmo-
nary dysfunction. Several studies are in agreement with this
result. In mechanically ventilated dogs, Ralph et al did not find
hypoxemia using a cuprophan membrane 121. In human studies,
Jacob et al showed that hypoxemia was dependent neither on
the membrane, the presence or absence of leukopenia, nor on
complement activation 1201. In a study on rabbits, Webster eta!
demonstrated that complement activation leading to acute
leukopenia was an insufficient insult to produce significant lung
injury [211. On the other hand, Carlon et a!, in five mechanical-
ly—ventilated patients, found hypoxemia and leukopenia 171.
Their patients had a moderate to severe pulmonary impairment
(venous pulmonary admixture: 20.9 5.1%) and a complement
activation during I-ID could, in this case, worsen the pulmonary
function. Finally, our study permits the conclusion that in acute
renal failure patients without major pulmonary injury a differ-
: [
60 T0 -f 60 +120 +240 300
ence in membrane biocompatibility has no deleterious conse-
quences on pulmonary function, at least after the first hour of
HD.
The increase in V02 was constant for the acetate and
bicarbonate dialysates for both membranes. This increase
lasted for two hours post-dialysis. The total CO2 elimination
was increased with the acetate dialysate and remained constant
with the bicarbonate one. The pH increased mildly with both
acetate and bicarbonate dialysates. The increase in V02 and
total VCO7 with acetate could be due to the oxidation of
acetate, which consumes 02 and produces CO2 with a RQ of
one [221. During HD, the acetate load approaches the maximal
metabolic capacity of acetate (300 mmoles - hr ') [231 and
oxidation of acetate represents up to 40% of the energetic
expenditure [22]. But, the metabolism of acetate can not
account for all of the increase in V02 since V02 increased also
with the bicarbonate dialysate. Alkalosis could be an additional
explanation, Indeed, alkalosis has been found to increase V02
[241 and VCO2 with a stable RE [251. Moreover, the increase in
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Fig. 1. Leukocyte count and platelet count during hemodial'f'.cis for
acute renal failure in mechanically ventilated patients: (Q---O) Group
I, Ac Cupro; (—•) Group 2, Ac PAN. Values are expressed as the
means + SCM. * significant difference from first value, P < 0.05.
—60 T0+ 10 +30 +60 240
40
a
30
4 Hemodialysis + Time, mm
Fig. 2. Respiratory parameters during he,nodialysis for acute renal
jilure in mechanically ventilated patients: (O---O) Group 1, Ac Cupro;(•—•) Group 2, Ac PAN; (--) Group 3, ic PAN. Values are
expressed as the means ÷ SEM. * significant difference from first value,
P < 0.05.
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Hemodialysis Time, mm
Fig. 3. Evolution of V02, VCO2 and respiratory exchange ratio (RE)
during hemodialysis for acute renal failure in mechanically ventilated
patients. Symbols are the same as Fig. 2. Each point of V02 and VCO2
is the mean of measurements during thirty mm for each patient. Values
of V02 and VCO2 are expressed as percent of the initial values (means
SEM). Initial values (ml. mm') are for Group 1: V02 = 212 8,
VCO2 = 217 6; for Group 2: V02 = 230 10, VCO2 = 235 7; for
Group 3: V02 = 226 21, VCO2 = 228 21. * significantly different
from pre-dialysis values, P < 0.05.
V02 is proportional to the degree of alkalosis 26]. Despite these
data, the rise in pH, which we found in our patients, was not
significant and, thus, could not explain the entire increase in
V02. Finally, it is of interest to observe that RE was decreased
in the post-dialysis period. This would suggest a dialysis in-
duced change in the quality of metabolized substrates, leading
to a lipolysis, and thus to an enhanced V02.
In conclusion, this study showed that: 1) the maintenance of
a constant ventilation avoided hypoxemia during HD; and 2)
V02 increased during HD.
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